Leonteq Securities AG (Guernsey Branch) Share Price

Certificat

XBXLTQ

CH1265332507

Market Closed - Swiss Exchange 08:50:00 24/06/2024 pm IST
100.4 CHF +0.22% Intraday chart for Leonteq Securities AG (Guernsey Branch)
3 months+1.93%
6 months+2.09%
Date Price Change
24/24/24 100.4 +0.22%
21/24/21 100.2 +0.22%
20/24/20 99.96 +0.09%

Delayed Quote Swiss Exchange

Last update June 24, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer LEONTEQ
XBXLTQ
ISINCH1265332507
Date issued 02/06/2023
Strike 292.8 CHF
Maturity 02/06/2025 (338 Days)
Parity 0.29 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 101.3 CHF
Lowest since issue 95.14 CHF
Spread 8 CHF
Spread %0.79%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.5 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.44%
Consensus
  1. Stock Market
  2. Certificates
  3. XBXLTQ Certificat